Adolescent Probiotics in Stressed Adolescents
Analysis of Brain and Immune Functions in Adolescents Using Probiotics
1 other identifier
interventional
104
1 country
2
Brief Summary
Stress is a normal human reaction to changes surrounding our reality, resulting in physical, emotional, and intellectual responses. Children and adolescents often experience high levels of stress. Age and gender may affect a child's ability to manage stress. Children and adolescents experiencing stress could be at an increased risk of poor cognitive, social, and emotional functioning. Probiotics are living microorganisms that could positively affect microbiota, support functions of numerous organs and systems, and overall human health. Most probiotics belong to the Lactobacillus genus. Probiotics can potentially support mental health, psychological function, and immune defenses. The purpose of this exploratory clinical trial is to investigate whether supplementation of the diets of adolescents experiencing moderate stress with the probiotic dietary supplement a blend of two probiotic Lactobacillus plantarum and one Lactobacillus brevis strains will support their emotions (e.g., psychological well-being, social relationship, stress levels, and self-efficacy), cognitive (e.g., attention, episodic and working memory) and immune functions (e.g., salivary IgA and salivary cytokine productions). This study is intended only to evaluate the dietary supplement's effect on the body's structure or function. Our investigation is not intended to mitigate, cure, treat, or prevent disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2024
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedMay 4, 2026
April 1, 2026
2.2 years
April 15, 2026
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Emotinal status and cognitive functions of participants
The NIH Toolbox was used to assess participants' emotional and cognitive functions. The Emotion Domain consisted of instruments evaluating psychological well-being, social relationships, stress, self-efficacy, and negative affect. Additionally, PROMIS CAT Emotional Support, Psychological Stress Experiences, and Sleep Disturbance tests were administered. The Cognition Domain test consisted of attention, episodic and working memories, language, and processing speed.
From enrollment (week 0), 8 weeks and 12 weeks (end of study)
Secondary Outcomes (2)
Changes in the immune functions of participants
From enrollment (week 0), 8 weeks and 12 weeks (end of study)
Evaluation of AM and PM cortisol levels
From enrollment (week 0), 8 weeks and 12 weeks (end of study)
Study Arms (2)
Probiotics supplement
EXPERIMENTALParticipants received the probiotics blend containing two Lactobacillus plantarum and one Lactobacillus brevis strains for 12 weeks. The probiotic blend contained 2 billion CFU bacteria. Stains are present in the mixture at a ratio of 2:1:1. Participants were taking them daily with meals, (preferably with a dinner meal) for 12 consecutive weeks. If the probiotic was not taken during dinner, it should be taken within 2 hours after dinner or with the next meal
Placebo cohort
PLACEBO COMPARATORThe participants started taking placebo capsules the day after the first visit, after collecting the AM saliva sample, and continued taking them daily (preferably with a dinner meal) for 12 consecutive weeks. If the capsule was not taken during dinner, it should be taken within 2 hours after dinner or with the next meal
Interventions
The participants started taking capsules the day after the first visit, after collecting the AM saliva sample, and continued taking them daily (preferably with a dinner meal) for 12 consecutive weeks. If the probiotic was not taken during dinner, it should be taken within 2 hours after dinner or with the next meal
The participants started taking placebo capsules the day after the first visit, after collecting the AM saliva sample, and continued taking them daily (preferably with a dinner meal) for 12 consecutive weeks. If the probiotic was not taken during dinner, it should be taken within 2 hours after dinner or with the next meal
Eligibility Criteria
You may qualify if:
- Participants: Males and females
- Participants: 12-20 years old
- Participants with sustained moderate stress levels as determined by the Perceived Stress Scale (PSS), average score 14-26
- Participants with BMI percentile \>5% and \<97%
- Participants receiving or not receiving cognitive behavioral therapy.
You may not qualify if:
- Participants less than 12 years of age or over 20 years of age at enrollment.
- Participants with PSS average scores less than 14 and more than 26.
- Participants with BMI percentile \<5% or \>97%
- Participants receiving selective serotonin reuptake inhibitors (SSRIs).
- Participants who take any nutraceutical having an effect on stress anxiety within 1 month before subject screening.
- Participants who are female and report being pregnant.
- Participants receiving immunosuppressive therapy.
- Participants having immune deficiencies.
- Adverse reactions to any probiotic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Kaneka Americas Holding Inc.collaborator
Study Sites (2)
Division Clinical Pharmacology, SOM, University of Utah
Salt Lake City, Utah, 84108, United States
University of Utah, Pediatrics and Primary Childrens Hospital
Salt Lake City, Utah, 84108, United States
Related Publications (1)
1. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A., and Colzato, L. S. (2015) A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48, 258-264 2. Chong, H. X., Yusoff, N. A. A., Hor, Y. Y., Lew, L. C., Jaafar, M. H., Choi, S. B., Yusoff, M. S. B., Wahid, N., Abdullah, M., Zakaria, N., Ong, K. L., Park, Y. H., and Liong, M. T. (2019) Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study. Benef Microbes 10, 355-373 3. Quagliato, L. A., and Nardi, A. E. (2018) Cytokine alterations in panic disorder: A systematic review. J Affect Disord 228, 91-96
BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
April 15, 2026
First Posted
May 4, 2026
Study Start
May 3, 2022
Primary Completion
July 22, 2024
Study Completion
November 25, 2024
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share